Neeta Somaiah Selected Research

Neeta Somaiah Research Topics

Disease

35	Neoplasms (Cancer) 05/2022 - 07/2010
26	Sarcoma (Soft Tissue Sarcoma) 05/2022 - 01/2012
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2018 - 11/2009
8	Liposarcoma 01/2022 - 05/2013
7	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2021 - 02/2009
5	Testicular Neoplasms (Testicular Cancer) 10/2019 - 01/2014
4	Nausea 01/2022 - 04/2017
4	Disease Progression 01/2022 - 12/2017
3	Fatigue 01/2022 - 12/2017
3	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 12/2017
3	Myxoid Liposarcoma 08/2017 - 04/2015
3	Lung Neoplasms (Lung Cancer) 01/2014 - 01/2011
2	Anemia 11/2021 - 04/2017
2	Leiomyosarcoma 02/2021 - 01/2017
2	Diarrhea 10/2020 - 12/2017
2	Alveolar Soft Part Sarcoma 01/2020 - 01/2018
2	Melanoma (Melanoma, Malignant) 05/2019 - 09/2018
2	Neoplasm Metastasis (Metastasis) 01/2018 - 04/2015
2	Cardiotoxicity 10/2017 - 01/2017
2	Synovial Sarcoma (Synovioma) 10/2017 - 04/2015
2	Thrombocytopenia (Thrombopenia) 08/2017 - 04/2017
1	Hemangiosarcoma (Angiosarcoma) 01/2022
1	Aggressive Fibromatosis (Desmoid) 01/2022
1	Abdominal Pain (Pain, Abdominal) 11/2021
1	Pain (Aches) 08/2021
1	Phyllodes Tumor (Cystosarcoma Phylloides) 04/2021
1	Alopecia (Baldness) 10/2020
1	Constipation 10/2020
1	Myalgia 10/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2018
1	Circulating Neoplastic Cells 01/2018
1	Hypertension (High Blood Pressure) 12/2017
1	Ewing Sarcoma (Sarcoma, Ewing) 10/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2017
1	Rare Diseases (Rare Disease) 06/2017

Drug/Important Bio-Agent (IBA)

5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2017
5	AntigensIBA 10/2019 - 01/2014
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2011
4	ripretinibIBA 12/2021 - 10/2020
4	pazopanib FDA Link 01/2021 - 11/2017
4	Immune Checkpoint InhibitorsIBA 01/2020 - 12/2017
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2010
3	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 02/2009
3	selinexorIBA 01/2022 - 08/2021
3	VimentinIBA 01/2018 - 03/2014
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2017
2	pembrolizumabIBA 01/2022 - 09/2018
2	palbociclibIBA 01/2022 - 01/2017
2	Ifosfamide FDA LinkGeneric 04/2021 - 10/2017
2	VaccinesIBA 11/2020 - 12/2017
2	Monoclonal AntibodiesIBA 03/2019 - 03/2014
2	Tyrosine Kinase InhibitorsIBA 12/2017 - 01/2016
2	Pharmaceutical PreparationsIBA 06/2017 - 04/2017
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 01/2014
1	Vinca AlkaloidsIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Cyclin-Dependent Kinase 4IBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2021
1	Gemcitabine FDA Link 01/2021
1	Recombinant ProteinsIBA 11/2020
1	Oncogene Proteins (Oncogene Protein)IBA 10/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2020
1	Transcription Factor 3IBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	olaratumabIBA 03/2019
1	RadiumIBA 01/2019
1	NivolumabIBA 09/2018
1	IpilimumabIBA 09/2018
1	TrabectedinIBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	mifamurtideIBA 12/2017
1	CytokinesIBA 12/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2017
1	Lapatinib (GW572016)FDA Link 11/2017
1	Vorinostat FDA Link 11/2017
1	Trastuzumab (Herceptin)FDA Link 11/2017
1	Everolimus FDA Link 11/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2017
1	Vincristine (Oncovin)FDA LinkGeneric 10/2017
1	Tumor Biomarkers (Tumor Markers)IBA 10/2017
1	Antineoplastic Agents (Antineoplastics)IBA 10/2017
1	amrubicinIBA 08/2017
1	SurvivinIBA 08/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2017
1	AnthracyclinesIBA 08/2017
1	DNA (Deoxyribonucleic Acid)IBA 06/2017

Therapy/Procedure

29	Therapeutics 05/2022 - 01/2012
9	Drug Therapy (Chemotherapy) 01/2022 - 07/2010
9	Immunotherapy 01/2022 - 01/2014
5	Biological Therapy 01/2014 - 07/2010
3	Radiotherapy 05/2022 - 01/2018
2	Precision Medicine 01/2022 - 08/2017
2	Investigational Therapies (Experimental Therapy) 01/2020 - 06/2017
2	Neoadjuvant Therapy 09/2018 - 04/2015
1	Duration of Therapy 11/2021